Literature DB >> 15520834

Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM).

A C Franzoi1, A Q C Araújo.   

Abstract

STUDY
DESIGN: Survey.
OBJECTIVE: To determine the disability profile of a group of patients with human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), using the Functional Independence Measure (FIM) to identify the most affected functional areas.
SETTING: Reference center for HTLV Rio de Janeiro, Brazil.
METHODS: A total of 72 patients (49 female and 23 male), consecutively referred by tertiary care centers, were assessed using the FIM.
RESULTS: The average FIM score was 108 (+/-12 SD) ranging from 58 to 122. The lowest items scores were obtained in locomotion and bladder management. When divided into two groups (above, and below or equal to the average score), there were significant differences (P<0.05) in age at time of assessment, in the degree of muscular power and in low back pain. There were no significant differences in terms of age of onset and duration of the disease.
CONCLUSIONS: The most affected areas in FIM motor items were locomotion (walk and stairs) and bladder management. Age, strength in lower limbs and low back pain interfere with functional activities in patients with HAM/TSP. The duration of the disease is not a significant factor for patient disabilities. The goals of rehabilitation in HAM/TSP patients should target the modifiable factors, such as pain, strength and the neurogenic bladder.

Entities:  

Mesh:

Year:  2005        PMID: 15520834     DOI: 10.1038/sj.sc.3101677

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  12 in total

1.  Dietary Intake and Serum Selenium Levels Influence the Outcome of HTLV-1 Infection.

Authors:  Effat Saghi; Abdolreza Norouzy; Mohsen Nematy; Lida Jarahi; Reza Boostani; Fariba Zemorshidi; Zohreh Vahidi; Houshang Rafatpanah
Journal:  Biol Trace Elem Res       Date:  2020-11-09       Impact factor: 3.738

2.  Update on Neurological Manifestations of HTLV-1 Infection.

Authors:  Abelardo Q-C Araujo
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

3.  Isokinetic trunk and knee muscle strengths and gait performance in walking patients with T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP).

Authors:  Masashi Miyazaki; Harutoshi Sakakima; Tatsushi Goto; Ryoji Kiyama; Toshio Matsuzaki; Kosei Ijiri; Yoshihiro Yoshida
Journal:  J Jpn Phys Ther Assoc       Date:  2011

4.  Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Ana Verena Galvão-Castro; Aidê Nunes; Ana Karina Galvão-Barroso; Thessika Hialla Almeida Araújo; Regina Helena Rathsam-Pinheiro; Ceuci Lima Xavier Nunes; Adriele Ribeiro; Monique Lírio; Noilson Lázaro Gonçalves; Sônia Lúcia Rangel; Cristiane Maria Carvalho Costa Dias; Daniele Piai Ozores; Selena Márcia Dubois-Mendes; Isabela Lima; André Luís Pereira Silva; Washington Luiz Abreu de Jesus; Fred Luciano Neves Santos; José Guilherme Reis de Oliveira; Yscela Vanessa Pimentel de Moraes; Adijeane Oliveira de Jesus; Francisco Daltro; Ney Boa-Sorte; Humberto Castro-Lima; Maria Luísa Carvalho Soliani
Journal:  Front Med (Lausanne)       Date:  2022-06-07

5.  Response to: RSBMT-2018-0270.R2 - Pain and quality of life in human T cell lymphotropic virus type 1 associated myelopathy or tropical spastic paraparesis after home-based exercise protocol: Randomized clinical trial.

Authors:  Maíra Carvalho Macêdo; Renata de Sousa Mota; Naiane Araújo Patrício; Abrahão Fontes Baptista; Antônio de Souza Andrade Filho; Katia Nunes Sá
Journal:  Rev Soc Bras Med Trop       Date:  2022-06-06       Impact factor: 2.141

Review 6.  Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives.

Authors:  Katia N Sá; Maíra C Macêdo; Rosana P Andrade; Selena D Mendes; José V Martins; Abrahão F Baptista
Journal:  J Multidiscip Healthc       Date:  2015-02-23

7.  Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing.

Authors:  Júlia Fonseca de Morais Caporali; Ludimila Labanca; Kyonis Rodrigues Florentino; Bárbara Oliveira Souza; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

8.  Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis.

Authors:  Naiane Araújo Patrício; Mônica Andrade Rios; Patrícia Carvalho Barbosa; Jéssica Ramos Ribeiro; Diogo Guedes Vidal; Kátia Nunes Sá; Abrahão Fontes Baptista
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-25       Impact factor: 1.581

9.  Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net).

Authors:  Ariella L G Coler-Reilly; Naoko Yagishita; Hiroko Suzuki; Tomoo Sato; Natsumi Araya; Eisuke Inoue; Ayako Takata; Yoshihisa Yamano
Journal:  Orphanet J Rare Dis       Date:  2016-05-25       Impact factor: 4.123

10.  Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test.

Authors:  Adine Adonis; Graham P Taylor
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.